StockCIK 1650664

Editas Medicine, Inc. (EDIT): Insider Trades and Fund Holdings

In the past 12 months, Editas Medicine, Inc. insiders reported 0 open-market purchases worth $0 and 3 sales worth $19K; 3 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$19KSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 4, 2026.

Recent EDIT insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 4	Sep 3	Gilmore Neil O'NeillCEO	CEO	▼ SELL10b5-1	5,124	3.04	$16K	−2.1%	Form 4 ↗
Sep 4	Sep 3	Linda BurklyEVP	EVP	▼ SELL10b5-1	709	3.04	$2K	−1.1%	Form 4 ↗
Sep 4	Sep 3	Amy ParisonCFO	CFO	▼ SELL10b5-1	453	3.04	$1K	−3.2%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Gilmore Neil O'Neill	CEO	$0	1	$16K	Sep 4, 2026
Linda Burkly	EVP	$0	1	$2K	Sep 4, 2026
Amy Parison	CFO	$0	1	$1K	Sep 4, 2026

Tracked funds that report EDIT

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	2,468,919	$8.00M	0.01%	▼ −37.8%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →